Results for tag: "Hypoxic Ischemic Encephalopathy Drug"

Hypoxic Ischemic Encephalopathy (HIE) is a type of brain injury caused by a lack of oxygen and blood flow to the brain. It is a major cause of disability and death in newborns. As a result, the development of drugs to treat HIE has become an important area of research. The HIE drug market is a subset of the larger Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological disorders, including HIE. These drugs are typically administered intravenously or orally, and can be used to reduce the severity of HIE symptoms. The HIE drug market is highly competitive, with many companies developing and marketing drugs to treat HIE. Some of the major players in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Other companies, such as Biogen, are also developing drugs to treat HIE. Show Less Read more